Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
All news
(page 61)
20 February 2026
EU Allocates €225M for Advanced Flu Vaccine Development
The EU funds next-gen flu vaccines to enhance protection, speed up development, and improve pandemic readiness through pre-commercial procurement.
20 February 2026
Umicore 2025 Full Year Results
Strong performance with €3.6B revenue, €847M EBITDA. Efficiency measures hit €100M target. Proposed €0.50/share dividend. Net debt at €1.4B, TRIR at 4.5.
20 February 2026
Uniper and GSPC Sign LNG Supply Deal
Starting 2028, up to 0.5 MTPA LNG will be delivered to India's west coast, enhancing energy ties and addressing supply-demand gaps.
20 February 2026
MGC Halts Construction at Dutch Facility
Construction of the MXDA facility in the Netherlands is discontinued due to cost, delays, and market conditions. Equipment removal is planned by 2029. Financial impacts are under review.
20 February 2026
Air Liquide Confirms 2025 Growth and Sets New Margin Goals
Record 2025 performance with increased sales, profits, and investments. New margin target for 2027 set. Dividend raised by 12.1%.
20 February 2026
Deutsche Infineum Develops Major Urban PV System in Germany
An 18MW PV system in Cologne will produce 18M kWh annually, aiding decarbonization and supporting local climate goals by 2027.
News type
Project Updates and Milestones
New Projects and Expansions
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Operational Changes and Investments
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
20 February 2026
Roche's Giredestrant NDA Accepted by FDA for Advanced Breast Cancer
FDA accepts giredestrant NDA based on phase III data showing reduced disease progression risk in ER-positive breast cancer. Decision expected by December 18, 2026.
20 February 2026
MOL Group Q4 2025 Results: Strong Downstream and Consumer Services Boost Performance
Upstream struggles amid tough conditions, while Downstream and Consumer Services thrive. Profit before tax drops 11% to USD 1.3B. 2026 guidance set at USD 1.5B.
20 February 2026
MOL Group Q4 and 2025 Results Released
Profit before tax fell 11% to USD 1.3B. Upstream faced challenges, while downstream grew. 2026 profit guidance set at USD 1.5B. Transition to holding structure and renewable expansion noted.
19 February 2026
Altris awarded EIC funding to industrialize sodium‑ion batteries
Secures €2.5M grant plus up to €10M equity to scale Prussian‑White sodium‑ion cathode production, expand European manufacturing, validate with industrial partners and accelerate commercial rollout.
19 February 2026
LanzaJet Secures $47M in New Funding, Valued at $650M
Existing investors boost LanzaJet's ATJ technology growth, supporting commercial deployment and securing feedstock supply through a multi-year tolling structure.
19 February 2026
Zenyaku's Rituxan Approved for Autoimmune Hemolytic Anemia Treatment
Rituxan gains approval for treating autoimmune hemolytic anemia, targeting B cells to reduce autoantibodies. Effective for warm AIHA, CAD, and PCH, offering an alternative to steroids.
19 February 2026
Technip Energies Appoints Jesse Stanley as President of Technologies & Products
Jesse Stanley joins as President, Technologies & Products, enhancing innovation and growth. The Executive Committee's new composition is announced.
19 February 2026
Asahi Kasei's Thin-Film Hall Elements Earn IEEE Milestone Recognition
Commercialized in 1983, thin-film Hall elements revolutionized magnetic sensors, enhancing electronics and energy efficiency, with over 50 billion units shipped globally.
19 February 2026
Infineum and RheinEnergie to Build Major Inner-City Solar Project in Cologne
An 18-megawatt solar installation in Cologne will generate 18 million kWh annually, aiding decarbonization and supporting local climate goals. Completion is set for 2027.
19 February 2026
Genentech's Venclexta and Acalabrutinib Combo Approved by FDA for Untreated CLL
FDA approves all-oral, fixed-duration regimen for CLL, reducing treatment time. AMPLIFY study shows 35% lower risk of progression or death compared to chemoimmunotherapy.
19 February 2026
Velocys Achieves 30% Cost Reduction in microFTL™ Technology Deployment
Standardisation and delivery efficiencies enhance capital efficiency for Altalto and NovaSAF 1 projects, advancing them toward final engineering and investment decisions.
19 February 2026
Lilly's Omvoh Maintains Steroid-Free Remission in Crohn's Patients for Three Years
Omvoh shows durable efficacy in Crohn's and UC, with low surgery rates and sustained symptom relief over three years, maintaining steroid-free remission in over 90% of patients.
19 February 2026
Carbon Neutral Fuels Chooses Johnson Matthey, Honeywell for UK E-Fuels Project
Project Starling will convert CO2 and water into sustainable aviation fuel, aiming for 25,000 tons annually by 2031, using advanced technologies for significant emissions savings.
19 February 2026
Johnson & Johnson's Rybrevant Faspro™ Shows 56% Response Rate in First-Line Head and Neck Cancer
The OrigAMI-4 study shows amivantamab with immunotherapy offers durable antitumor activity in recurrent/metastatic head and neck cancer, improving outcomes over current treatments.
19 February 2026
Ercros Board Rejects Bondalti Takeover Bid
The board cites strategic misalignment, potential debt increase, and shareholder opposition as reasons for rejecting the unsolicited bid.
19 February 2026
Takeda's Phase 3 Study on Pediatric Ulcerative Colitis
Vedolizumab shows promise in treating pediatric ulcerative colitis, achieving 47.3% remission at 54 weeks, with a safety profile consistent with adult use.
19 February 2026
Toray's Ultrasuede™ Chosen by Case Furniture
Ultrasuede™ is used in Case's Ella Lounge and 675 Chair, enhancing sustainability and design. Toray expands its European presence with a new showroom in Portugal.
19 February 2026
BASF Introduces Circalo for Low Carbon Ethanol Production
Circalo connects farmers and ethanol producers to reduce carbon intensity, aligning with Section 45Z, using xarvio tools for data verification and compliance.
19 February 2026
Trinseo's Rho Plant Achieves ISO 9001 Certification
The Rho facility's ISO 9001:2015 certification highlights its quality management and ability to produce high-quality recycled monomers. Other Trinseo sites also hold this certification.
19 February 2026
BASF Launches AdBlue GE Using 100% Green Electricity
AdBlue GE is made with renewable electricity, reducing CO2 emissions. It matches conventional AdBlue in quality and performance. Initial launch in Switzerland, with plans for wider European rollout.
19 February 2026
Repsol Reports €2.568 Billion Adjusted Net Income
Net income rose 8.1% to €1.899B in 2025. Adjusted net income fell 15.1% amid market volatility and geopolitical issues. Resilient performance supports strategic goals.
19 February 2026
TechnipFMC Q4 2025 Financial Results
Subsea orders hit $2.3B in Q4; full-year orders $10.1B. Shareholder distributions $188M in Q4, $1B annually. Revenue $2.5B, net income $242.7M, adjusted EBITDA $440.5M, margin 17.5%.
19 February 2026
Statkraft's Former Employees Advance Biofuel Tech at Tofte
Statkraft shifts focus to core technologies, transferring biofuel expertise to a new company led by former employees, aiming to commercialize HTL technology for emissions reduction.
19 February 2026
Merck Reports Positive Phase 3 Trial Results for ENFLONSIA in High-Risk Infants and Children
ENFLONSIA shows consistent safety and efficacy in high-risk infants over two RSV seasons, supporting expanded use for children under 2.
← Previous
Next →
